Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Lantheus Holdings (LNTH)

Lantheus Holdings (LNTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Lantheus Releases Comprehensive Strategic Plan for Progenics

--Lantheus' In-Place Infrastructure and Commercial Capabilities Will Ensure the Progress of AZEDRA, and the PyL and 1095 Programs

LNTH : 20.92 (-2.88%)
Lantheus Holdings (LNTH) Tops Q3 Earnings and Revenue Estimates

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 12.00% and 2.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

LNTH : 20.92 (-2.88%)
Lantheus Holdings: 3Q Earnings Snapshot

NORTH BILLERICA, Mass. (AP) _ Lantheus Holdings Inc. (LNTH) on Thursday reported third-quarter net income of $4.9 million.

LNTH : 20.92 (-2.88%)
Lantheus Holdings, Inc. Reports Third Quarter 2019 Financial Results

Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovative diagnostic...

LNTH : 20.92 (-2.88%)
Lantheus Holdings to Present at the Credit Suisse 28th Annual Healthcare Conference

Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovative...

LNTH : 20.92 (-2.88%)
Progenics Strongly Agrees With ISS Recommendation that Velan Group SHOULD NOT Get Majority Control of the Board of Directors

ISS Recognizes that Shareholders Should Have Full Information About the Lantheus Transaction Before Making Significant Decisions About the Company

PGNX : 5.64 (-2.08%)
LNTH : 20.92 (-2.88%)
Progenics Highlights Additional Serious Concerns About Velan Capital, L.P.

Flags Velan's Knowledge of Lantheus Transaction Weeks Before It Was Made Public

PGNX : 5.64 (-2.08%)
LNTH : 20.92 (-2.88%)
Lantheus Holdings to Host Third Quarter 2019 Earnings Conference Call on October 31, 2019 at 8:00 a.m. Eastern Time

Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH) today announced that it will host a conference call at 8:00 a.m. ET on Thursday, October 31, 2019, to discuss its financial and operating results...

LNTH : 20.92 (-2.88%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, PGNX, DOVA Shareholders About Its Ongoing Investigations

EQNX::TICKER_START (OtherOTC:HLND),(PinkSheets:TNCB),(NASDAQ:PGNX),(NASDAQ:DOVA),(NASDAQ:FCBC),(NASDAQ:RBNC),(NASDAQ:LNTH),(Nasdaq First North Sweden:SOBI), EQNX::TICKER_END

HLND : 8.2800 (-1.19%)
FCBC : 31.19 (-0.45%)
RBNC : 22.15 (-0.23%)
PGNX : 5.64 (-2.08%)
LNTH : 20.92 (-2.88%)
DOVA : 28.04 (+0.14%)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Progenics Pharmaceuticals, Inc. ("Progenics" or the "Company") (NASDAQ: PGNX) in connection...

PGNX : 5.64 (-2.08%)
LNTH : 20.92 (-2.88%)
PROGENICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Progenics Pharmaceuticals, Inc. - PGNX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Progenics Pharmaceuticals, Inc. (NasdaqGS: PGNX)...

PGNX : 5.64 (-2.08%)
LNTH : 20.92 (-2.88%)
Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Progenics Pharmaceuticals, Inc. has obtained a Fair Price in its sale to Lantheus Holdings, Inc.

Ademi & O'Reilly, LLP is investigating Progenics (Nasdaq: PGNX) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of Progenics to Lantheus.

LNTH : 20.92 (-2.88%)
PGNX : 5.64 (-2.08%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Progenics Pharmaceuticals, Inc. to Lantheus Holdings, Inc. is Fair to Shareholders

The following statement is being issued by Levi & Korsinsky, LLP:

PGNX : 5.64 (-2.08%)
LNTH : 20.92 (-2.88%)
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) on Behalf of Progenics Shareholders and Encourages Progenics Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) on behalf of Progenics shareholders concerning the proposed...

LNTH : 20.92 (-2.88%)
PGNX : 5.64 (-2.08%)
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Progenics Pharmaceuticals, Inc.

Rowley Law PLLC is investigating potential claims against Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the...

PGNX : 5.64 (-2.08%)
LNTH : 20.92 (-2.88%)
Progenics Merger Investigation: Halper Sadeh LLP Announces Investigation into Whether the Sale of Progenics Pharmaceuticals, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - PGNX

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) to Lantheus Holdings, Inc. ("Lantheus") for 0.2502 shares of Lantheus...

LNTH : 20.92 (-2.88%)
PGNX : 5.64 (-2.08%)
Lantheus to Acquire Progenics to Form a Leading Precision Diagnostics Imaging and Therapeutics Company

--Lantheus' Proven Commercial, Manufacturing and Operational Excellence Well Positioned to Optimize the Combined Company's Innovative Diagnostic and Radiopharmaceutical Portfolio

LNTH : 20.92 (-2.88%)
PGNX : 5.64 (-2.08%)
Lantheus Holdings to Present at the Wells Fargo Securities 2019 Healthcare Conference

Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovative...

WFC : 54.01 (+0.39%)
LNTH : 20.92 (-2.88%)
Lantheus Holdings (LNTH) Q2 Earnings Match Estimates

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 0.00% and -3.49%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

LNTH : 20.92 (-2.88%)
Lantheus Holdings: 2Q Earnings Snapshot

NORTH BILLERICA, Mass. (AP) _ Lantheus Holdings Inc. (LNTH) on Thursday reported second-quarter net income of $6.4 million.

LNTH : 20.92 (-2.88%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +1.50 , AIZ +0.28 , SBAC +0.23 , SO +0.76 , WELL +1.26
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar